In Vitro & In Vivo Diagnostic Substances companies: boards of directors (SIC 2835)

Organizations
18
Directors
175
Average board size
9.7
Organization Directors CEO
Achieve Life Sciences Inc. Nasdaq: ACHV · Seattle, United States 16 Andrew D. Goldberg
IDEXX Laboratories Inc. Nasdaq: IDXX · Westbrook, United States 13 Jonathan Jay Mazelsky
ImmuCell Corporation Nasdaq: ICCC · Portland, United States 13 Boekhorst Paul Francis Olivier Te
Neogen Corporation Nasdaq: NEOG · Lansing, United States 13 Mikheal Nassif
QuidelOrtho Corporation Nasdaq: QDEL · SAN Diego, United States 13 Douglas C. Bryant
Lantheus Holdings Inc. Nasdaq: LNTH · Bedford, United States 11 Mary Anne Heino
Myriad Genetics Inc. Nasdaq: MYGN · Salt Lake City, United States 11 Paul J. Diaz
VolitionRX Limited NYSE American: VNRX · Henderson, Singapore 11 Cameron John Reynolds
Cardio Diagnostics Holdings Inc. Nasdaq: CDIO · Chicago, United States 10 Meeshanthini Dogan
Celldex Therapeutics Inc. Nasdaq: CLDX · Hampton, United States 10 Anthony S. Marucci
Q/C Technologies Inc. Nasdaq: QCLS · New York, United States 10 —
Alpha Teknova Inc. Nasdaq: TKNO · Hollister, United States 9 Stephen Gunstream
Intellia Therapeutics Inc. Nasdaq: NTLA · Cambridge, United States 9 John M. Leonard
Biomerica Inc. Nasdaq: BMRA · Irvine, United States 8 Zackary S. Irani
Insight Molecular Diagnostics Inc. Nasdaq: IMDX · Nashville, United States 6 Josh Riggs
Anbio Biotechnology Nasdaq: NNNN · Frankfurt AM Main, Germany 4 —
Trinity Biotech plc Nasdaq: TRIB · Wicklow, Ireland 4 —
Virax Biolabs Group Limited Nasdaq: VRAX · Lanarkshire, United Kingdom 4 —

Organizations whose headquarters, sector or industry code is on file and that have at least one current director. Sectors not on file are derived from the industry code (an approximate match to GICS). Board sizes count every current seat on record; see where our data comes from.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.